Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Michael A. Matthay, Carolyn S. Calfee, Hanjing Zhuo, B. Taylor Thompson, Jennifer G. Wilson, Joseph E. Levitt, Angela J. Rogers, Jeffrey E. Gotts, Jeanine P. Wiener-Kronish, Ednan K. Bajwa, Michael P. Donahoe, Bryan J. McVerry, Luis A. Ortiz, Matthew Exline, John W. Christman, Jason Abbott, Kevin L. Delucchi, Lizette Caballero, Melanie McMillan, David H. McKennaKathleen D. Liu
Dive into the research topics of 'Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial'. Together they form a unique fingerprint.